NasdaqGM:ZLABBiotechs
Will Expedited Approval of TTFields for Pancreatic Cancer Shift Zai Lab's (ZLAB) Market Outlook?
In August 2025, Zai Lab Limited announced that the China National Medical Products Administration (NMPA) granted Innovative Medical Device Designation for Tumor Treating Fields (TTFields) in pancreatic cancer, based on positive Phase 3 PANOVA-3 trial results.
This designation enables expedited regulatory review for TTFields, potentially accelerating patient access to a new therapy for one of the most challenging cancers in China.
We'll now explore how expedited approval for TTFields in...